705262-64-2 Usage
Structure
Quinoxaline derivative with a bromo group and an ethylene glycol moiety
Usage
Building block for organic synthesis and medicinal chemistry, development of drugs and pharmaceuticals
Potential activities
Antiviral and antibacterial
Value
Can be used as a valuable intermediate in the synthesis of various biologically active compounds due to its diverse reactivity and biological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 705262-64-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,5,2,6 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 705262-64:
(8*7)+(7*0)+(6*5)+(5*2)+(4*6)+(3*2)+(2*6)+(1*4)=142
142 % 10 = 2
So 705262-64-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrN2O2/c11-7-1-2-8-9(5-7)13-10(6-12-8)15-4-3-14/h1-2,5-6,14H,3-4H2
705262-64-2Relevant academic research and scientific papers
FUSED PYRAZOLE DERIVATIVES AS TGF-BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF FIBROSIS AND NEOPLASMS
-
Page/Page column 26-27, (2010/02/14)
The disclosed invention is directed to compounds of the formula: Formula (I) and methods of using these compounds.
NOVEL COMPOUNDS AS PHARMACEUTICAL AGENTS
-
Page 49, (2010/02/07)
The current invention relates to compounds of the formula:(Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
